The functional role of corticosterone (CORT) in regulating migratory hyperphagia and lipogenesis was investigated in an annual migrant, the dark-eyed junco (Junco hyemalis). Intraperitoneal injections of either dexamethasone (9 mg DXM/500 mL of 5% EtOH in saline, ) to inhibit an increase in n p 10 baseline CORT or saline (5% EtOH, ) were given every n p 9 48 h for 15 d after transfer from short (10.5L : 13.5D) to long (15.5L : 8.5D) days. Food intake, body mass, furcular fat deposition scores, and nocturnal migratory activity were recorded for 29 d after photostimulation. Both groups showed the same increase in daily food intake over the study period (DXM p %, %). Controls began to increase baseline 52 control p 41 CORT and mass about 2 wk after photostimulation. DXMtreated birds maintained low CORT and did not increase mass or CORT until injections ceased, at which time they gained mass at the same rate shown earlier by controls. DXM-treated birds did not show greater levels of migratory activity despite experiencing an increase in energy intake during the CORTinhibited period. Collectively, the results support the migration modulation hypothesis, illustrating how an increase in baseline CORT is needed to support the development of migratory condition. We address the apparent conflict with earlier studies on CORT and migratory food intake and propose a model in which migratory hyperphagia is supported by changes in centrally regulated responses to CORT that can occur even if CORT remains low and lipogenesis is regulated predominantly by peripheral mechanisms that require an increase in baseline CORT.
Introduction
Preparation for optimal migration in birds requires the interaction between endogenously controlled processes and external signals such as photoperiod, temperature, and food availability (Holberton and Able 1992; Holberton 1993; Berthold 1996; Gwinner 1996a Gwinner , 1996b Piersma et al. 2000; Lõhmus et al. 2003a ). Migratory condition is broadly characterized by increased food intake (hyperphagia) and, often, a shift in diet preference, which lead to changes in body composition through fat deposition McWilliams and Karasov 2001; Long and Stouffer 2003) and muscle hypertrophy (Marsh 1984; Gaunt et al. 1990 ). Further, in captivity, migrants often show increased locomotor activity (Zugunruhe) when held under conditions similar to when their free-living conspecifics migrate (e.g., Berthold 1996; Gwinner 1996a Gwinner , 1996b . The behavioral and physiological changes associated with migratory condition may be stimulated not only at the time of initial departure but also repeatedly throughout the journey when migrants stop to replenish energy reserves en route.
The physiological mechanisms supporting body-condition changes in migrants may be complex because energetic needs can change as dramatically as environmental conditions such as food, weather, and habitat suitability change during migration. Corticosterone (CORT), the major energy-regulating steroid in birds (Holmes and Phillips 1976; Harvey et al. 1984) , has been linked with predictable as well as unpredictable demands for increased food intake and lipogenesis during the migratory and nonmigratory periods (Wingfield and Silverin 1986; Berdanier 1989; Gray et al. 1990; Astheimer et al. 1992; Holberton et al. 1996 Holberton et al. , 1999 Breuner et al. 1998; Holberton 1999) . However, the functional role that CORT plays in regulating migration-related changes in behavior and physiology is not yet well understood even though it was first proposed as a major factor in the development of migratory condition several decades ago (e.g., Meier and Farner 1964; Meier et al. 1965) .
Many field and laboratory studies on a variety of bird species have shown that baseline plasma CORT levels, as well as the acute increase in CORT in response to capture and handling (hereafter referred to as the "adrenocortical response"), can change significantly between the nonmigratory and migratory periods (Holberton et al. 1996 Romero et al. 1997 Romero et al. , 1998 Holberton 1999; Piersma et al. 2000; Long and Holberton 2004) . For example, Holberton et al. (1996) found that, in autumn, free-living gray catbirds (Dumetella carolinensis) that had completed prebasic molt and had begun to fatten had higher baseline CORT levels and a reduced adrenocortical response compared with catbirds similarly sampled before coming into migratory condition, suggesting that CORT facilitated this development of migratory condition. More recently, changes in baseline CORT and/or the adrenocortical response accompanying periods of migratory fattening have been observed under controlled laboratory conditions in several species of landbirds (Romero et al. 1997; Holberton 1999 ) and shorebirds (Landys et al. 2004a) , further suggesting that adjustments in CORT secretion can occur in the absence of environmental perturbations such as predation or storms.
Studies on captive birds have shown that changes in CORT secretion patterns can occur on a relatively coarse, seasonal scale. Piersma et al. (2000) observed seasonal peaks of baseline CORT during the migratory period in captive red knots (Calidris canutus). Romero et al. (1997) found not only that whitecrowned sparrows (Zonotrichia leucophrys) show changes in CORT secretion across different stages of the annual cycle but also that the extent of the change varied with the amount of fat deposition: higher baseline CORT levels were coincident with greater fat reserves observed during the spring migratory period compared with CORT levels observed when birds put on less fat in autumn. These patterns suggest that, in addition to the rapid increase in baseline CORT in response to acute challenges, longer-term shifts in CORT secretion patterns (baseline and/or adrenocortical response) can be made to help migrants meet predictable seasonal changes in energy demand (e.g., migration modulation hypothesis [MMH]; Holberton et al. 1996) .
Within the migratory period, baseline CORT and the adrenocortical response can also vary Jenni et al. 2000; Piersma et al. 2000) . Long and Holberton (2004) found that in hermit thrushes (Catharus guttatus) sampled during migration, leaner birds, presumably with a greater need to put on fat, expressed markedly higher baseline CORT and a lower adrenocortical response than those in better condition whose fattening rates may have been slowing down. Extremely high baseline CORT levels have been found in very lean migrants on stopover (Schwabl et al. 1991; Gwinner et al. 1992) , suggesting that CORT either was facilitating fuel recovery via fattening or, as observed during stage 3 fasting (Cherel et al. 1988; Jenni et al. 2000) , was acting catabolically on skeletal muscle to procure an alternative energy source in the absence of fat, a well-documented response to extremely high and chronic CORT levels (Dallman et al. 1993 (Dallman et al. , 1994 . Several studies have shown that a reduced adrenocortical response is more likely when baseline CORT is already elevated, a way in which skeletal muscle protein, an important commodity for migrating birds, can be protected from the hormone's catabolic action for as long as possible (Holberton et al. 1996 Jenni et al. 2000; Long and Holberton 2004) . Elevated baseline CORT observed near the end of the refueling stage (Landys-Ciannelli et al. 2002) may also serve as a "readiness" cue, interacting with orientation mechanisms to provide the impetus to depart in the seasonally appropriate direction (Belthoff and Dufty 1998; Piersma et al. 2000; Lõhmus et al. 2003a) .
While there is ample evidence that changes in CORT secretion are linked with predictable migration-dependent changes in energy demand, the functional role that the hormone plays in regulating migratory behavior and physiology is still poorly understood. The main objective in this study was to determine experimentally whether an increase in baseline CORT is necessary for the development of migratory condition. To do this, we inhibited the ability of the hypothalamic-pituitary-adrenal axis to stimulate the increase in endogenous CORT secretion that occurs as birds come into migratory condition (Holberton 1999) . Normally, CORT secretion is self-regulating through negative feedback of higher plasma levels of CORT at the level of the hypothalamus and/or pituitary. Dexamethasone (DXM), a synthetic glucocorticosteroid (GC), is a CORT agonist and, acting in the same manner as CORT, can decrease endogenous CORT production via negative feedback on the hypothalamicpituitary cascade at the level of the pituitary in birds and mammals (de Kloet et al. 1974 (de Kloet et al. , 1975 Westerhof et al. 1994; Cole et al. 2000) . Although DXM can mimic CORT in this way, several studies, in vivo and in vitro, on birds and mammals have shown that DXM is not identical to CORT (see "Discussion"). Thus, we focused on the dark-eyed junco (Junco hyemalis) because much is known about its migratory behavior in the field and in captivity. We used DXM to investigate the role of CORT in promoting two key components of migratory condition, changes in body mass via fat deposition and increased food intake, as the birds were photostimulated into migratory condition. Specifically, we tested a component of the MMH, that an increase in endogenous baseline CORT is necessary for migratory hyperphagia and lipogenesis. We predicted that DXMtreated, and thus CORT-inhibited, birds would show no increase in daily food intake and would fail to fatten as well as controls. An important objective was to not eliminate endogenous CORT production entirely but to inhibit a migrant's ability to increase CORT above short-day baseline levels. To look for any cumulative effects of the handling schedule (injections and body mass recordings every 48 h) on the birds, we also compared body mass changes between saline-injected controls and a similar group of juncos housed and maintained in the same rooms, at the same time, but not injected. This latter group was weighed only twice during the study period.
Material and Methods
All birds were captured in September-December 1997 at baited sites in Lafayette and Yalobusha counties in Mississippi. Birds were captured by mist nets or potter traps and held in indoor aviaries until experiments began the subsequent January. All birds were provided food (equal mix of commercial turkey starter and white millet), water, and water-soluble vitamins ad lib. until released at the end of the study. Before the study began, the birds were transferred to individual commercial bird cages ( cm). In January 1998, two treat-40 cm # 40 cm # 40 ment groups comprising 10 DXM-treated birds and nine salinetreated birds were established. Birds were nonrandomly assigned to a treatment injection group to begin the study with equal group means and standard errors for body mass. Ten additional birds were selected as noninjected controls to compare their body masses with those of the more intensively handled saline-injected controls at the beginning and end of the study (days 1 and 23, respectively).
While Silastic implants are commonly used to deliver steroids and steroidlike substances, they are often unpredictable in the amount and time course of hormone delivery. Unfortunately, the small size of juncos precluded the use of more reliable, but larger, osmotic minipumps (e.g., Alzet) for delivering controlled doses of a particular substance. Intramuscular injections on small birds with relatively small pectoralis muscles can result in muscle tissue damage. Therefore, we chose repeated intraperitoneal (IP) injection for dose-delivery control. Injections were given at a 45Њ angle approximately 1 cm below the sternum and approximately 3-4 mm to the left or right of the body's midpoint. Care was taken to avoid puncturing an air sac by ensuring that the needle tip went only 1-2 mm beyond the peritoneal muscle wall. There were no indications of air sac puncture in any of the birds during the study. On the basis of protocol for birds used by Westerhof et al. (1994) , all birds were injected every h. The injection treatment period 48 ‫ע‬ 1 was determined a priori to begin as the birds were transferred from short-(10.5L : 13.5D) to long-day (15.5L : 8.5D) photoperiod and to continue until the first day that the controlinjected group, via a paired-sample t-test, showed a significant increase in body mass above their initial mass in response to long days. Body mass ‫10.0ע(‬ g) and subcutaneous furcular fat deposition scores (described in Holberton 1999) were recorded for all injected birds at each injection time (because of unplanned scheduling constraints, body mass and fat scores were not recorded on day 3) and continued every 48 h until the study ended. Daily food intake ‫10.0ע(‬ g) was determined by measuring the difference between the initial food mass recorded at the beginning of each monitoring interval and the subsequent food mass measured at the end of every 4-d interval and dividing this difference by the number of days in the interval. All uneaten food was accounted for by partially covering the plastic food cups to prevent the birds from scratching food out of the cup and by covering all sides of the cages with clear plastic sheets. Any food removed from the cup and not eaten could be recovered, weighed, and included when calculating each bird's food intake. The amount of nocturnal perchhopping activity, as a measure of migratory restlessness (Zugunruhe), was measured each night. Each cage had one solid perch and one active perch that, when depressed, registered on an electronic counter. The counters were automatically turned on a half-hour after lights went out and turned off a half-hour before lights came on throughout the study.
For the DXM-treated birds, we used the mass-specific dose of DXM (500 mg/kg body mass) successfully used by Westerhof et al. (1994) to suppress CORT for at least 48 h in pigeons. It is extremely difficult to adjust dose (via injection volume) for differences in individual body mass in small birds while also keeping injection volume constant to minimize the amount of solution that these small birds have to absorb in their peritoneum. Therefore, we established the DXM solution concentration based on the initial lean body mass of 95% of the juncos (18.0 g) to ensure that the birds received at least the effective doses used previously (Westerhof et al. 1994) . For a dose equivalent to 500 mg DXM/kg body mass, we used a DXM dose of 9 mg/18 g body mass with an injection volume of 500 mL (9 mg DXM/0.018 mg DXM/500 mL injection). To make kg p 9 the solution, 18.0 mg DXM (Sigma Aldrich, cat. no. D1756) was first dissolved in 5 mL EtOH and then brought up to a total volume of 100 mL with 0.9% sterile physiological saline to yield a final concentration of 18 mg/1,000 mL and to deliver 9 mg DXM in a 500 mL IP injection. Control birds received 500 mL of the 5% EtOH solution in 0.9% physiological saline. Injections began the day before the birds were switched from short to long days to ensure that the effect of DXM was in place well before the birds experienced an increase in photoperiod (within 1 h; Cole et al. 2000) . All injections were given at least 1 h but no more than 2 h after lights came on to allow the birds to break their nocturnal fast before handling began. On the basis of a priori design, the injection period continued for 15 d after the first long day.
Blood samples were taken at key times to confirm treatment effects on endogenous baseline CORT concentration. To ensure getting the best representation of true baseline CORT, each bird was captured and a small blood sample (≤80 mL whole blood) was taken within 3 min of entering the aviary. Plasma CORT Figure 1 . plasma levels of endogenous baseline corticoMean ‫ע‬ SE sterone (ng/mL) in juncos before (day 1, before injection), during (days 9 and 17), and after (day 29) the injection period (days 1-15) of either saline (open circles, ) or dexamethasone (filled circles, ) n p 9 n p 10 in response to transfer from short-day (10.5L : 13.5D) to long-day (15.5L : 8.5D) photoperiod. The two groups differed only on days 9 and 17. concentrations were measured by radioimmunoassay following Wingfield et al. (1992) . All samples were run within a single assay, thereby eliminating interassay variation. Within-assay percent coefficient of variation, based on a plasma pool, was 12.1% and the sensitivity of the standard curve was 7.8 pg/mL.
Birds were moved from free-flight cages to individual cages on January 10, 1998, and continued on short days (10.5L : 13.5D). To take measurements and administer injections in a timely manner, both treatment groups were divided in half and the birds in each group were randomly assigned to one of two rooms, resulting in a staggering of the data-collection schedules by 1 d. Thus, all birds experienced the same treatment schedule, but data for one-half of each treatment group were collected on alternate mornings. On the mornings of February 13 and 14, the birds were weighed (to the nearest 0.1 g) and scored for furcular fat deposition. Blood samples were collected at this time to measure pretreatment baseline CORT levels. The photoperiod was changed to 15.5L : 8.5D on these days of the first injection, making February 13 and 14 the first relatively long days. Thus, February 14 and 15, respectively, were the first full long days for each of the two rooms and are collectively referred to as day 1 in text and figures. Subsequent blood samples were taken during the injectioneffects period on days 9 and 17 (48 h after the last injection on day 15) and 12 d later on day 29. All procedures were done under the approval of the University of Mississippi Institutional Animal Care and Use guidelines (UMIACUC 98-028). Nonparametric and parametric (with appropriate transformations noted as needed) tests, with two-tailed hypotheses when needed, were used throughout the analyses. Treatment-dependent effects on specific variables and how they may have changed during the study were investigated using two-factor repeated-measures ANOVA, with Fisher's protected least squares difference (PLSD) used in post hoc tests.
Results

Handling Effects on Body Mass: Noninjected Controls versus Saline Controls
The intensity of the injection and handling schedule did not influence the birds' change in body mass during the study period. The two control groups (injected and noninjected) were equal in body size (noninjected control mean wing chord p saline-injected controls, baseline CORT had not increased significantly by day 9 (day 1 vs. day 9: mean p 52.0% ‫ע‬ 0.35% increase, paired-sample t-test, ), but by day 17, base-P p 0.433 line CORT levels had more than doubled (mean p 115% ‫ע‬ increase from day 1, paired-sample t-test, ), 0.40% P p 0.005 with an final overall mean increase of by day 193.0% ‫ע‬ 0.58% 29 (day 1 vs. day 29: paired-sample t-test, ). In con-P p 0.001 ) juncos ben p 9 n p 10 fore (day 1) and after (days 2-29) being transferred from short-day (10.5L : 13.5D) to long-day (15.5L : 8.5D) photoperiod. For salineinjected birds, significant mass gain began on day 15, and birds remained at mass greater than that on day 1 throughout the rest of the study ( , day 1 vs. days 15-29 indicated by asterisk). Dexa-P ! 0.05 methasone-treated birds did not begin to gain mass above their leanest period (day 5) until day 25 ( , day 5 vs. days 25, 27, 29 indicated P ! 0.05 by asterisk). A solid horizontal line depicting the initial (day 1) mean body mass for the two groups pooled is provided for reference. fat score for saline-injected (open circles, Mean ‫ע‬ SE n p ) and dexamethasone-treated (filled circles, ) juncos before 9 n p 10 (day 1) and after (days 2-29) being transferred from short-day (10.5L : 13.5D) to long-day (15.5L : 8.5D) photoperiod. The groups differed on days 23-29 (as indicated by asterisk). A solid horizontal line depicting the initial (day 1) mean fat score for the two groups pooled is provided for reference.
trast, DXM-treated birds showed no such increase in baseline CORT during the treatment period (day 1 vs. day 9:
, ; day 1 vs. 17: mean p Ϫ63% ‫ע‬ 0.07% P p 0.005 mean p , , paired-sample t-test, for both Ϫ3.0% ‫ע‬ 0.23% P p 0.322 comparisons). However, by the end of the 2-wk postinjection period, DXM-treated birds increased significantly in baseline CORT (day 1 vs. day 29: mean percent change p 110% ‫ע‬ , , paired-sample t-test), equal to levels found 0.3% P p 0.011 in controls (day 29: control ng/mL vs. mean p 9.57 ‫ע‬ 0.9 DXM ng/mL, , , mean p 10.78 ‫ע‬ 1.5 F p 0.44 P p 0.515
Fisher's PLSD; Fig. 1 ).
Treatment Effects on Body Mass and Fat
In response to long-day exposure, controls showed the first significant increase in body mass on day 15 (day 1 vs. days 5-13: ; day 1 vs. day 15, , paired-sampled t-P 1 0.05 P p 0.036 tests), and, as determined a priori, this became the last day of injections. Body mass on days 17-29 was significantly higher than on day 1 for controls, and their mass gain slowed or ceased toward the end of the study ( , paired-sample t-tests P ! 0.001 for all comparisons with day 1). Body mass did not differ between the two treatment groups until day 17 (day 17: MannWhitney U-test, ; Fig. 2 ). Unlike controls, DXM-treated P ! 0.05 birds showed an initial small but significant decline in body mass during the first 5 d of injections (day 5 vs. day 1: P p , paired-sample t-test) but remained stable throughout the 0.001 rest of the DXM exposure period (day 5 vs. days 7-17: P 1 for all comparisons). DXM-treated birds first began to put 0.05 on mass 48 h after the last injection (day 17 vs. day 19: P p Controls began to put on visible fat within the first 2 wk after being transferred to long days, which showed the first significant increase in fat score compared with day 1 (mean fat SE, ) on day 17 (mean fat score p 0.78 ‫ע‬ 0.3 mode p 0.5 SE, , , paired-sample tscore p 1.5 ‫ע‬ 0.3 mode p 1 P p 0.044 test; Fig. 3 ). This was near the time in which they also showed an increase in body mass (day 15). Controls reached a maxi- ) and dexamethasone-treated (filled circles, ) juncos n p 9 n p 10 over each 4-d interval throughout the 29-d period after the birds were transferred from short-day (10.5L : 13.5D) to long-day (15.5L : 8.5D) photoperiod. The groups did not differ at any time during the study. A solid horizontal line depicting the initial interval of mean daily food intake for the two groups pooled is provided for reference. mum fat score on day 23 (mean fat SE, no score p 2.3 ‫ע‬ 0.2 mode) that was significantly greater than their initial fat score (day 1 vs. day 23:
, paired-sample t-test). In contrast, P p 0.0005 DXM-treated birds remained lean throughout the DXM exposure period (day 1 mean fat SE, score p 0.75 ‫ע‬ 0.2 ; day 17 mean fat SE, mode p 0.5 score p 1.1 ‫ע‬ 0.2 mode p ; day 1 vs. days 5-17, , paired-sample t-test; Fig. 3 ). 0.5 P 1 0.05 Fat score did not differ significantly between the two groups during the first 21 d ( , Mann-Whitney U-test for all P 1 0.05 comparisons). The proportion of birds with a trace of fat ( ) was equal between the two groups on day 1 score p 0.5 ( %; %) and day 9 ( %; control p 67 DXM p 70 control p 67 %), but by day 15, this proportion declined in con-DXM p 60 trols to 33%, while 60% of DXM-treated birds remained at this fat level. By day 17, 89% of controls had scores ≥1, compared with only 60% of DXM birds. DXM-treated birds never reached the same level of fat deposition as controls (e.g., control vs. DXM, day 23:
; day 25: ; day 27: P p 0.01 P p 0.029 P p ; day 29:
; Mann-Whitney U-test for all com-0.028 P p 0.014 parisons). When DXM-treated birds finally reached their maximum fat scores (day 25), the scores were similar to those of controls during the previous week, when controls were undergoing significant fat deposition, suggesting that DXMtreated birds were a week or so behind the controls in fat deposition (DXM day 25 vs. control days 17, 19, and 21: P 1 , Mann-Whitney U-test).
0.05
Mass Change as a Result of Fat Deposition
Fat deposition contributed significantly to the change in body mass. Within the first week of the treatment period, individual fat score was a reliable predictor of body mass for both of the injected groups (days 1, 5, and 7; Figs. 2, 3) .
Treatment Effects on Food Intake
Food intake increased over the study period, but CORT inhibition through DXM treatment did not influence it in any way (main effect of treatment:
, ; main effect Fig. 4) . By the end of the injection period (interval 14-17), both groups 4 p days showed a similar and significant increase in daily food intake compared with the initial period (interval 1 vs. 4: control mean g/d, , , increase p 1.59 ‫ע‬ 0.30 41.0% ‫ע‬ 0.08% P p 0.001 P p , paired-sample t-test for within-group changes in daily 0.007 food intake; DXM mean g/d, increase p 1.84 ‫ע‬ 0.53 52% ‫ע‬ , paired-sample t-test for within-group changes in daily 0.15% ) and dexamethasone-treated (filled circles, n p 9 ) juncos throughout the 29-d study period. For clarity, only n p 10 data from every other night are shown. Although dexamethasonetreated birds tended to have lower Zugunruhe, the groups did not differ significantly at any time.
food intake, , ; Mann-Whitney U-test for P p 0.0068 P p 0.568 between-group comparisons of percent increase in food intake). By the end of the study (interval 26-29) , the groups 7 p days continued to show similar levels of increased food intake (daily food intake increase: interval 1 vs. interval 7: control mean g/d, , ; DXM increase p 1.15 ‫ע‬ 0.32 41.0% ‫ע‬ 0.09% P p 0.002 mean g/d, , ; increase p 2.26 ‫ע‬ 0.59 65% ‫ע‬ 0.20% P p 0.004 paired-sample t-test for both within-group comparisons, P p ; Mann-Whitney U-test for between-group comparisons 0.221 of percent increase in food intake; Fig. 4) .
Treatment Effects on Migratory Activity
Both groups showed an increase in nocturnal Zugunruhe in response to increased photoperiod. Although DXM-treated birds tended to show less activity, there was no significant difference between the two groups in their response to photoperiod (two-factor repeated-measures ANOVA: main effect of treatment , , effect of day F p 0.46 P p 0. , with transformations for heteroscedasticity), nor P p 0.6929 did the groups differ in the amount of Zugunruhe on any night during the study (days 1-29: Mann-Whitney U-test, ; P 1 0.05 Fig. 5 ).
Discussion
First, we wished to minimize the possibility that the experimental design itself could confound our results when a major hormone such as CORT, which plays a critical role in homeostasis but can be affected by disturbance, is manipulated. Although the injected birds were handled frequently, the inclusion of a minimally handled group of birds that showed the same overall mass gain as those that were handled every other day assured us that our handling regime did not affect the birds' ability to develop migratory condition. Therefore, we can interpret potential differences between the two main treatment groups with greater confidence.
The results from this study provide direct support for the hypothesis that an increase in baseline CORT plays a pivotal role in supporting migratory lipogenesis (Meier and Farner 1964; Meier et al. 1965; Holberton et al. 1996) . As expected for this and other songbird species similarly treated (e.g., Holberton 1999; R. L. Holberton, unpublished data), the salineinjected birds responded to photostimulation with an increase in baseline CORT and in body mass in about 2 wk after the transition from short to long days, while the CORT-inhibited birds did not. Control baseline CORT more than doubled between days 1 and 17, preceding the period of greatest mass gain, which occurred between days 19 and 25. This change in baseline CORT is similar in magnitude to that observed in other studies on captive songbirds, including dark-eyed juncos and free-living birds sampled before and after the onset of migration or during refueling periods on stopover (Holberton et al. 1996; Holberton 1999; Landys-Ciannelli et al. 2002) . In contrast, DXM-treated birds, which did not experience elevated CORT during the initial 17-d period, did not begin to gain mass until CORT inhibition was released (i.e., after day 17, 48 h after the last injection).
The mass gain observed in both treatment groups, regardless of when it occurred, most likely reflected lipid deposition as variation in fat score closely mirrored changes in body mass. During periods of stasis, which the CORT-inhibited group experienced for a longer period early in the study, fat score and body mass were either at their minimum or approaching maximum and lacked sufficient variation to result in significant correlation. However, during periods of mass gain, when greater variation among individuals may be more likely, fat score became a reliable predictor of body mass, suggesting that much, if not all, of the active mass gain in both groups was a result of a net increase in lipid stores. However, the contribution of muscle mass change to body mass change via protein catabolism or tissue hypertrophy from skeletal muscle fiber recruitment and glycogen stores cannot be excluded. Future studies that measure these important contributions to energy stores would provide a more complete picture of how migrants meet their energy demand (Marsh 1984; Gaunt et al. 1990; Jenni and Jenni-Eiermann 1992; Totzke et al. 1998; Jenni et al. 2000; Bairlein 2002) .
In this study, the relationship between baseline CORT and migratory fattening was more apparent than CORT's relationship to migratory food intake. Although the percent change in daily food intake by the controls increased after the birds were transferred from short-to long-day photoperiod, so, too, did the daily food intake for the CORT-inhibited birds. In fact, there was no tendency for food intake by CORT-inhibited birds to differ from controls before, during, or after the injection period. At first glance, these results appear to contradict the hypothesis proposed by Meier and colleagues (e.g., Meier and Farner 1964; Meier et al. 1965) and numerous studies in which exogenous CORT treatment was linked to food intake (Wingfield and Silverin 1986; Gray et al. 1990; Landys et al. 2004b ). We feel, however, that these results are indeed congruent with earlier studies and that the apparent discrepancy lies in how CORT's activity was manipulated. Landys et al. (2004b) found that the GC antagonist RU486 (mifepristone) resulted in a decline in food intake in captive white-crowned sparrows (Zonotrichia leucophrys) brought into spring migratory condition. As an antagonist, RU486 blocks GC effects by binding to the hormone's GC receptor (GR) and, thus, directly inhibits its activation. If peripherally administered RU486 crosses the blood-brain barrier to reach feeding control regions in the brain, blocking the ability of circulating CORT to reach GR there, then a decline in CORT-dependent, centrally regulated hyperphagia would be expected, particularly if migratory hyperphagia is regulated by GR (Landys et al. 2004b (Landys et al. , 2006 . In contrast, peripherally administered DXM in low to moderate doses cannot cross the blood-brain barrier (de Kloet et al. 1974; Koch et al. 2002) . If the administration method of DXM used in this study resulted in circulating DXM levels within this range and did not cross into the brain, but the low plasma levels of endogenous CORT, as observed still available in our DXMtreated birds, could reach central-feeding control regions, then our results, when considered with those from Landys et al. (2004b) , are indeed congruent. We present a model in which the regulation of migratory food intake and of migratory fattening are independent and occur at different levels in the body, through different concentrations of the same signal, baseline CORT.
Collectively, the studies suggest that the development of the two major components of migratory condition is under different levels of regulation (centrally vs. peripherally) and the seasonal responses to different CORT levels are CORT concentration dependent and site specific (Holberton et al. 1996; Landys et al. 2006 ). CORT's role in supporting increased hyperphagia appears to be regulated centrally, as suggested by the full expression of food intake when low, baseline levels of CORT remained available to reach the brain in DXM-treated birds (this study) but were blocked by the use of RU486 (Landys et al. 2004b) . Seasonal increases in food intake rate as an integral part of migratory condition may not require an increase in circulating CORT but could be the result of increased sensitivity of GC and mineralocorticosteroid receptors and a variety of central and peripheral signals from the gut and brain (e.g., prolactin, neuropeptide Y, cholecystokinin, leptin) that are known to help regulate food intake in vertebrates (Kuenzel 1994; Richardson et al. 1995; Boswell 2001; Boswell et al. 2002; Koch et al. 2002; Landys et al. 2006 ).
CORT's role in promoting migratory lipogenesis may be regulated peripherally and requires above-baseline CORT levels to promote fat deposition. Seasonally dependent migratory fat deposition may be influenced by CORT through its direct or indirect regulation of the enzymes (via thyroid and growth hormones, insulin, etc.) involved with lipid synthesis (e.g., hepatic fatty acid synthase) and lipid storage in adipose and muscle tissues (e.g., adipose or muscle lipoprotein lipase) as well as proteins needed for lipid transport (Borron et al. 1979; Amatruda et al. 1983; Back et al. 1986; Wilson et al. 1986; Ramenofsky 1990; Roncero and Goodridge 1992; Ramenofsky et al. 1999; Egeler et al. 2000) . Recent evidence in our lab suggests that even when lipids are available in the plasma, without elevated CORT, birds are unable to store them (R. L. Holberton, unpublished data). More studies linking CORT with the actions of other hormones and their activities in migratory birds are sorely needed to better understand the cellular and molecular basis of these phenomena.
The mass-specific dose of DXM successfully used by Westerhof et al. (1994) , via intravenous injection, to reduce endogenous CORT in pigeons was just as effective as IP injections in juncos. Mass gain in DXM-treated birds did not begin until after the last 48-h postinjection period, suggesting that the time course of the DXM absorbance into the bloodstream from the peritoneum, its ability to reduce endogenous CORT, and its subsequent clearance from the blood were essentially the same as those reported by Westerhof et al. (1994) for the same massspecific dose despite the different delivery route. Endogenous CORT levels of the chronically treated DXM birds eventually reached that of controls (day 29), indicating that chronic exposure to this DXM dose did not permanently affect the birds' abilities to elevate baseline CORT or to respond to that increase. However, although DXM-treated birds gained mass during the postinjection period and finally reached a mass similar to that of controls, they never put on as much fat as the controls did. It is possible that DXM exposure had long-term effects beyond the injection period, but the fact that the rate of posttreatment mass gain through fat deposition by DXM-treated birds was identical to that of the controls during their initial onset of mass accumulation suggests otherwise. It is more likely that a "sensitive window" for an optimal response to upregulating lipogenic mechanisms after the initial stimulus for the development of migratory condition was received too late for DXMtreated birds.
A wide variety of approaches can be used in hormone studies, and an animal's exposure to CORT can be manipulated by more than one method. We selected DXM to create a condition in which migrants retained nonmigratory levels of CORT but were prevented from experiencing an increase above them. RU486 is also a progesterone receptor antagonist (Landys et al. 2004b) . Its ability to stimulate or inhibit levels of plasma prolactin (at least in mammals), another hormone linked with the development of migratory condition (Meier and Farner 1964; Meier et al. 1965 ) and a powerful stimulator of food intake (Sotowska-Brochocka et al. 1986; Koch et al. 2004) , could have added confounding variables to the study. Had we used RU486, we may have blocked responses to low CORT levels, but we may also have increased endogenous plasma CORT levels (Spencer et al. 1998; Landys et al. 2004b ). Any GR not bound by RU486, as well as mineralocorticosteroid receptors, which also bind to CORT, may remain available to it. The receptors are found throughout the avian brain and the periphery (e.g., liver, gut, and the eye; diBattista et al. 1985; Vylitova et al. 1998) , and how they function to support migration is unknown. Finally, we wished to avoid entirely blocking CORT activity (centrally, peripherally, or both) as RU486 may do because this would be an unnatural condition. We confirmed that our attempt to produce a normal nonmigratory condition was successful as the DXM-treated birds did not experience an absence of CORT but, rather, expressed endogenous CORT levels on days 9 and 17 similar to those observed in the birds on short days. Thus, plasma CORT levels (and their ability to reach the brain) were not completely abolished during the injection period, a condition that would be abnormal because low plasma corticosterone levels are necessary for maintenance activities regulating daily energy balance (Holmes and Phillips 1976; Harvey et al. 1984; Dallman et al. 1994 ).
There appears to be no "perfect" approach to manipulating an essential hormone such as CORT that has multiple functions throughout the lifetime of an organism, and we carefully considered how DXM could otherwise affect our birds. While DXM is considered a synthetic GC, it differs from CORT in several key biochemical properties (Sigma Aldrich, DXM cat (Carlstedt-Duke et al. 1977) , does not have the same binding dynamics (e.g., affinity and specificity) with corticosteroid receptors or binding globulins, and does not always produce the same effects on target tissue as CORT (Carlstedt-Duke et al. 1977; Miller et al. 1992; de Kloet et al. 1998) . Although CORT appears to cross the blood-brain barrier at low concentrations, low to moderate amounts of DXM do not because of the breakdown of DXM by mdr1a P-glycoprotein in the endothelia of the blood-brain barrier (de Kloet et al. 1998; Cole et al. 2000) . Unfortunately, we do not know the extent and time course of DXM absorption into the blood from the peritoneum or how DXM is cleared compared with intramuscular, intravenous, or oral administration used in the majority of studies to date. But if the dose used in this study (500 mg/kg), albeit relatively high if delivered by other methods, could reach the brain after being absorbed from the peritoneum, we might expect additive effects on food intake compared with controls if DXM acted like CORT. Although we have failed to detect any dose-dependent variation in food intake in our other studies, with juncos and other species, delivering different doses of DXM IP in the same experimental design as in this study (R. L. Holberton, unpublished data) , future studies could determine any effect of DXM on central regulation of food intake by combining DXM treatments with a GR antagonist such as RU486.
Regardless of where DXM may occur in the body, it is not biochemically identical to CORT, and we may not expect it to mimic CORT entirely. It has been shown that, like CORT, DXM can, in vitro, enhance the effects of insulin on lipogenic activity (Amatruda et al. 1983; Moon 1998 ) and, at much lower concentrations than used in this study, increase food intake in intact ring doves, Streptopelia risoria, a nonmigratory species (Koch et al. 2002) . However, other studies in birds that directly compared DXM with other GCs have found different and often opposite responses among treatments (Carlstedt-Duke et al. 1977; Joseph and Ramachandran 1992, 1993; Patel et al. 2004) . DXM treatments often result in responses interpreted as "adrenocortical insufficiency," while comparable CORT treatments result in "adrenocortical excess" (Joseph and Ramachandran 1992; Miller et al. 1992; de Kloet 2000; Patel et al. 2004 ). Further, DXM is sufficiently different from CORT to not bind with the CORT antibody (Esoterix) used in our radioimmunoassay for CORT. If it did, we would expect plasma samples from DXM-treated birds to yield much higher values than the CORT values found in controls. Finally, Westerhof et al. (1994) not only found differential responses to various glucocorticoids in their ability to inhibit endogenous CORT secretion in pigeons, they also concluded that birds, in general, may be more sensitive to hypothalamic-hypophyseal-adrenal suppression via GC levels compared with mammals, making direct comparisons between mammalian studies, in which most of the work on CORT agonists and antagonists have been done, and avian studies challenging.
Although DXM may not mimic CORT's effects, particularly on peripheral carbohydrate or lipid metabolism in birds (Joseph and Ramachandran 1992, 1993; Patel et al. 2004 ; R. L. Holberton, unpublished data), we could not rule out its possible effects, as a GC agonist, on muscle protein. Our DXM-treated birds showed an initial decline in body mass between days 1 and 5, but they started the study with greater mass than controls, and, despite the mass loss, DXM-treated birds did not differ from controls on day 5, nor did they continue to lose mass despite another 12 d of DXM exposure as one might expect if DXM, acting like CORT, was stimulating muscle protein catabolism (Dallman et al. 1993 (Dallman et al. , 1994 Joseph and Ramachandran 1993; Westerhof et al. 1994) . As found with food intake, different doses of DXM used in our other studies did not result in a dose-dependent response in mass loss or higher plasma metabolites of protein catabolism than controls (R. L. Holberton, unpublished data), further suggesting that DXM may not promote catabolism of skeletal muscle protein in migratory birds in the same way that elevated CORT can (Schwabl et al. 1991; Holberton et al. 1996; Holberton 1999; Jenni et al. 2000) .
Finally, the question remains: If the CORT-inhibited birds failed to gain mass in spite of increasing their food intake as controls, what did the birds do with that added energy taken in? Elevated CORT has been shown to increase locomotor activity in a wide variety of vertebrates (Astheimer et al. 1992; Dunlap 1995; Breuner et al. 1998; Cash and Holberton 1999) , and DXM, if acting like CORT, could have increased the activity of the birds, resulting in a net decrease in stored energy. Unfortunately, diurnal locomotor activity was not recorded in this study, but it is clear that DXM-treated birds failed to show higher levels of nocturnal activity than controls. Two recent studies in our lab using juncos and white-throated sparrows (Zonotrichia albicollis) have not found DXM-treated birds to show higher diurnal locomotor activity compared with controls, at least during the time periods monitored (C. M. Wilson and R. L. Holberton, unpublished manuscript; J. Long, unpublished data). Because the inability to gain mass while showing an increase in food intake has now been demonstrated in our lab in three separate studies using two bird species (R. L. Holberton, unpublished data), it may be that DXM-treated birds have different absorption or excretion dynamics, and further study is warranted.
In summary, the cumulative evidence from many studies provides support for the hypothesis first proposed several decades ago by Meier and colleagues that CORT plays a key role in regulating food intake and fat deposition in migratory birds (Meier and Farner 1964; Meier et al. 1965) . The functional role of CORT in promoting these activities remains unknown. The migration modulation hypothesis was initially proposed to explain how changes in baseline CORT, as well as the adrenocortical response, observed as birds came into migratory condition, could help a migrant meet the predictable changes in energy demand that the period of migration requires (Holberton et al. 1996; Holberton 1999; Long and Holberton 2004) . Changes in receptor density and distribution could explain how levels of CORT at or above "baseline" could promote the behavioral and metabolic activities regulated either centrally or peripherally, working in concert with a suite of other hormones (Dallman et al. 1993 (Dallman et al. , 1994 Wingfield 1994; Holberton 1999 ; reviewed in Landys et al. 2006) . Both CORT and prolactin influence neuropeptide Y and cholecystokinin activity that can be upregulated to meet a migrant's need to store fuel (Richardson et al. 1993; Kuenzel 1994; Boswell 2001; Strader and Buntin 2001; Boswell et al. 2002; Koch et al. 2002 Koch et al. , 2004 , and many studies have now illustrated that CORT plays an important role in potentiating insulin's role in lipogenesis and carbohydrate metabolism (Amatruda et al. 1983; Joseph and Ramachandran 1992, 1993; Dallman et al. 1993 Dallman et al. , 1994 ). Shortterm elevated baseline CORT may also serve as a departure cue, perhaps in concert with adipose sources of leptin, to signal when sufficient energy reserves have been accumulated and to help select the appropriate direction for departure (Piersma et al. 2000; Lõhmus et al. 2003a Lõhmus et al. , 2003b . Through their ability to cope with predictable as well as unpredictable changes in energy demand within and across seasons, along with their great diversity in strategies for reaching their destination, migratory birds provide an excellent system for looking at the molecular and cellular basis of how animals meet their energy demand throughout the annual cycle.
